Bioresponsive nanomedicines based on dynamic covalent bonds

Engineering dynamic covalent bond-based nanosystems for delivery of antimicrobials against bacterial infections

Nanodrug delivery systems (NDDS) continue to be explored as novel strategies enhance therapy outcomes and combat microbial resistance. The need for the formulation of smart drug delivery systems for targeting infection sites calls for the engineering of responsive chemical designs such as dynamic covalent bonds (DCBs). Stimuli response due to DCBs incorporated into nanosystems are emerging as an alternative way to target infection sites, thus enhancing the delivery of antibacterial agents. This leads to the eradication of bacterial infections and the reduction of antimicrobial resistance. Incorporating DCBs on the backbone of the nanoparticles endows the systems with several properties, including self-healing, controlled disassembly, and stimuli responsiveness, which are beneficial in the delivery and release of the antimicrobial at the infection site. This review provides a comprehensive and current overview of conventional DCBs-based nanosystems, stimuli-responsive DCBs-based nanosystems, and targeted DCBs-based nanosystems that have been reported in the literature for antibacterial delivery. The review emphasizes the DCBs used in their design, the nanomaterials constructed, the drug release-triggering stimuli, and the antibacterial efficacy of the reported DCBs-based nanosystems. Additionally, the review underlines future strategies that can be used to improve the potential of DCBs-based nanosystems to treat bacterial infections and overcome antibacterial resistance.

A nanomedicine composed of polymer-ss-DOX and polymer-Ce6 prodrugs with monoclonal antibody targeting effect for anti-tumor chemo-photodynamic synergetic therapy

Anticancer drugs used for systemic chemotherapy often exhibit off-target toxicity and uncontrolled drug release due to their lack of targeting. To improve the bioavailability of drugs and reduce side effects, we have developed a mixed micelle of nanomedicine composed of two prodrugs with surface modified monoclonal antibody for cancer therapy. In this system, Nimotuzumab was used as targeting ligands of the mixed micelles (named as DCMMs) that is composed of polymer-doxorubicin prodrug (abbreviated as PEG-b-P(GMA-ss-DOX)) and maleimide polyethylene glycol-chlorin e6 (abbreviated as Mal-PEG-Ce6). The mixed micelles modified with Nimotuzumab (named as NTZ-DCMMs) bind to overexpressed EGFR receptors on Hepatoma-22 (H22) cells. Disulfide bonds in PEG-b-P(GMA-ss-DOX) are disrupted in tumor microenvironment, inducing the reduction-responsive release of DOX and leading to tumor cell apoptosis. Simultaneously, Chlorin e6 (Ce6) produced plenty of singlet oxygen (1O2) under laser irradiation to kill tumor cells. In vivo biological distribution and antineoplastic effect experiments demonstrate that NTZ-DCMMs enhanced drug enrichment at tumor sites through targeting function of antibody, dramatically suppressing tumor growth and mitigating cardiotoxicity of drugs. All results prove that NTZ-DCMMs have the ability to actively target H22 cells and quickly respond to tumor microenvironment, which is expected to become an intelligent and multifunctional drug delivery carrier for efficient chemotherapy and photodynamic therapy of hepatoma. STATEMENT OF SIGNIFICANCE: Anticancer drugs used for systemic chemotherapy often exhibit off-target toxicity due to their lack of targeting. Therefore, it's necessary to develop effective, targeted, and collaborative treatment strategies. We construct a mixed micelle of nanomedicine based on two polymer prodrugs and modified with monoclonal antibody on surface for cancer therapy. Under the tumor cell microenvironment, the disulfide bonds of polymer-ss-DOX were broken, effectively triggering DOX release. The photosensitizer Ce6 could generate a large amount of ROS under light, which synergistically promotes tumor cell apoptosis. By coupling antibodies to the hydrophilic segments of polymer micelles, drugs can be specifically delivered. Compared with monotherapy, the combination of chemotherapy and photodynamic therapy can significantly enhance the therapeutic effect of liver cancer.

The Dynamic Chemistry of Orthoesters and Trialkoxysilanes: Making Supramolecular Hosts Adaptive, Fluxional, and Degradable

ConspectusThe encapsulation of ions into macro(bi)cyclic hosts lies at the core of supramolecular chemistry. While chemically inert hosts such as crown ethers (synthesis) and cyclodextrins (Febreze) have enabled real-world applications, there is a wider and accelerating trend toward functional molecules and materials that are stimuli-responsive, degradable, or recyclable. To endow supramolecular hosts with these properties, a deviation from ether C-O bonds is required, and functional groups that engage in equilibrium reactions under relatively mild conditions are needed.In this Account, we describe our group's work on supramolecular hosts that comprise orthoester and trialkoxysilane bridgeheads. In their simplest structural realization, these compounds resemble both Cram's crown ethers (macrocycles with oxygen donor atoms) and Lehn's cryptands (macrobicycles with 3-fold symmetry). It is therefore not surprising that these new hosts were found to have a natural propensity to bind cations relatively strongly. In recent work, we were also able to create anion-binding hosts by placing disubstituted urea motifs at the center of the tripodal architecture. Structural modifications of either the terminal substituents (e.g., H vs CH3 on the bridgehead), the diol (e.g., chiral), or the bridgehead atom itself (Si vs C) were found to have profound implications on the guest-binding properties.What makes orthoester/trialkoxysilane hosts truly unique is their dynamic covalent chemistry. The ability to conduct exchange reactions with alcohols at the bridgehead carbon or silicon atom is first and foremost an opportunity to develop highly efficient syntheses. Indeed, all hosts presented in this Account were prepared via templated self-assembly in yields of up to 90%. This efficiency is remarkable because the macrobicyclic architecture is established in one single step from at least five components. A second opportunity presented by dynamic bridgeheads is that suitable mixtures of orthoester hosts or their subcomponents can be adaptive, i.e. they respond to the presence of guests such that the addition of a certain guest can dictate the formation of a preferred host. In an extreme example of dynamic adaptivity, we found that ammonium ions can fulfill the dual role of catalyst for orthoester exchange and cationic template for efficient host formation, representing an unprecedented example of a fluxional supramolecular complex. The third implication of dynamic bridgeheads is due to the reaction of orthoesters and trialkoxysilanes with water instead of alcohols. We describe in detail how the hydrolysis rate differs strongly between O,O,O-orthoesters, S,S,S-trithioorthoesters, and trialkoxysilanes and how it is tunable by the choice of substituents and pH.We expect that the fundamental insights into exchange and degradation kinetics described in this Account will be useful far beyond supramolecular chemistry.

Super-resolution imaging of antibody-conjugated biodegradable periodic mesoporous organosilica nanoparticles for targeted chemotherapy of prostate cancer

Biodegradable periodic mesoporous organosilica nanoparticles (nanoPMOs) are widely used as responsive drug delivery platforms for targeted chemotherapy of cancer. However, the evaluation of their properties such as surface functionality and biodegradability is still challenging, which has a significant impact on the efficiency of chemotherapy. In this study, we have applied direct stochastic optical reconstruction microscopy (dSTORM), a single-molecule super-resolution microscopy technique, to quantify the degradation of nanoPMOs triggered by glutathione and the multivalency of antibody-conjugated nanoPMOs. Subsequently, the effect of these properties on cancer cell targeting, drug loading and release capability, and anticancer activity is also studied. Due to the higher spatial resolution at the nanoscale, dSTORM imaging is able to reveal the structural properties (i.e., size and shape) of fluorescent and biodegradable nanoPMOs. The quantification of nanoPMOs' biodegradation using dSTORM imaging demonstrates their excellent structure-dependent degradation behavior at a higher glutathione concentration. The surface functionality of anti-M6PR antibody-conjugated nanoPMOs as quantified by dSTORM imaging plays a key role in prostate cancer cell labeling: oriented antibody is more effective than random ones, while high multivalency is also effective. The higher biodegradability and cancer cell-targeting properties of nanorods conjugated with oriented antibody (EAB4H) effectively deliver the anticancer drug doxorubicin to cancer cells, exhibiting potent anticancer effects.

Bioapplication of cyclodextrin-containing montmorillonite

Recent progresses in the integration of CDs and montmorillonite, as well as applications of CD-containing montmorillonite hybrid host systems are summarized in this review. Several efficient synthesis strategies, such as ion exchange, metal coordination, supramolecular strategies, polymerizations and organic synthesis methods, have been discussed during the preparation of CDs/montmorillonite hybrid composites. In particular, diverse instrumental techniques were highly recommended for characterizing the as-obtained hybrid systems, including their chemical composition and structures, crystallinity, surface/self-assembled morphologies, as well as other particular physiochemical properties, providing a direct guide for promoting the desired structures and exploring various applications. It should be noted that the introduction of functional groups, as well as the integration of CDs and montmorillonite granted the thus obtained CD-containing montmorillonite hybrid host systems a lot of unique features, providing great opportunities for expanding the practical applications to a series of biological and environmental areas, such as biosensors, sorption and decontamination of bio/environmental hazardous materials, biostudies about aqueous dispersity, stability and biocompatibility, drug loading and target delivery, controlled and sustained drug release, as well as antibacterial.